Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-3701
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features ; volume:10 ; number:1 ; day:13 ; month:3 ; year:2020 ; pages:1-12 ; date:12.2020
Cell & bioscience ; 10, Heft 1 (13.3.2020), 1-12, 12.2020
- Creator
-
Cai, Xiong
Li, Heli
Kaplan, David E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13578-020-00395-2
- URN
-
urn:nbn:de:101:1-2020053023493024389338
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cai, Xiong
- Li, Heli
- Kaplan, David E.
- SpringerLink (Online service)
Other Objects (12)
A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma
Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies
A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib
Prolonged Survival of a Patient with Advanced-Stage Combined Hepatocellular-Cholangiocarcinoma
Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study
Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends
A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma
Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies
A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib
Prolonged Survival of a Patient with Advanced-Stage Combined Hepatocellular-Cholangiocarcinoma
Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study
Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends
A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma
Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies
A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib
Prolonged Survival of a Patient with Advanced-Stage Combined Hepatocellular-Cholangiocarcinoma
Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study